Exploring the potential public health benefits of universal influenza vaccine. – MIDAS

Exploring the potential public health benefits of universal influenza vaccine.

Abstract

: In ABM, the universal vaccine with a conservative VE estimate given once to 18 to 49-year-olds reduced influenza cases among all age groups in Years 2-4 following its introduction. Reduced influenza burden may occur sooner if VE of universal vaccines exceeds that assumed in these models.

MIDAS Network Members

Kenneth Smith

Professor
University of Pittsburgh

Richard Zimmerman

Professor
University of Pittsburgh

Citation:

DePasse JV, Nowalk MP, Smith KJ, Raviotta JM, Shim E, Zimmerman RK, Brown ST. (2019). Exploring the potential public health benefits of universal influenza vaccine. Human vaccines & immunotherapeutics, 15(12)